Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti-TNF failure-getting closer to the truth. Authors' reply
until further notice
SourceAlimentary Pharmacology & Therapeutics, 52, 7, (2020), pp. 1255-1256
Article / Letter to editor
Display more detailsDisplay less details
Alimentary Pharmacology & Therapeutics
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.